Lactic Acidosis, Hypoglycemia, and Eosinophilia: Novel Markers of Antibody‐Mediated Rejection Causing Graft Ischemia

Historically, minimal significance has been given to the humoral immune response after liver transplantation and despite antibodies against human leukocyte antigens (HLAs) being present in 10% to 20% of patients awaiting transplant, the incidence of antibody-mediated rejection (AMR) after ABO compatible (ABO-C) liver transplantation is low.(1) Donor-specific antibodies (DSAs) can lead to early graft loss,(2) but most patients awaiting liver...